• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

BiBBInstruments

0.53 SEK

+1.15 %

Less than 1K followers

BIBB

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.15 %
+31.19 %
-57.98 %
-77.79 %
-70.75 %
-75.31 %
-76.90 %
-88.48 %
-89.17 %

BiBBInstruments operates in the medical technology sector. The company develops biopsy instruments based on its own technology platform. The technology is mainly used in specialist healthcare and surgical departments in the treatment of various forms of cancer. The products are sold as disposable instruments with a developed drilling function and are used at the diagnostic stage. The company was founded in 2013 and is headquartered in Lund.

Read more
Market cap
85.32M SEK
Turnover
19.57K SEK
Revenue
400K
EBIT %
-3,667.5 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
21.8
2026

Interim report Q2'26

6.11
2026

Interim report Q3'26

12.2
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release6/12/2026, 2:27 PM

BibbInstruments AB: Bulletin from the Annual General Meeting of BiBBInstruments AB

BiBBInstruments
Press release5/21/2026, 6:57 AM

BibbInstruments AB: Mayo Clinic presents first clinical case with EndoDrill[®] GI in the lower GI tract at ESGE Days 2026

BiBBInstruments
Regulatory press release5/11/2026, 6:55 AM

BibbInstruments AB: Notice of annual general meeting in BiBBInstruments AB

BiBBInstruments

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/7/2026, 7:40 AM

BibbInstruments AB: Henry Ford Health Presented Case Series with Positive Clinical Results for EndoDrill GI at DDW 2026 in Chicago

BiBBInstruments
Regulatory press release4/22/2026, 3:18 PM

BibbInstruments AB: BiBBInstruments carries out a directed issue of shares to guarantors

BiBBInstruments
Regulatory press release4/17/2026, 1:14 PM

BibbInstruments AB: Shareholding notification in BiBBInstruments AB (publ)

BiBBInstruments
Regulatory press release4/15/2026, 12:01 PM

BibbInstruments AB: BiBBInstruments announces outcome in rights issue

BiBBInstruments
Regulatory press release4/1/2026, 8:51 AM

BibbInstruments AB: BiBBInstruments receives additional subscription intentions in the ongoing rights issue

BiBBInstruments
Regulatory press release3/25/2026, 8:54 PM

BibbInstruments AB: Correction: BiBBInstruments AB (publ) publishes updated information document in connection with rights issue - incorrect ISIN code for the share

BiBBInstruments
Regulatory press release3/24/2026, 4:34 PM

BibbInstruments AB: BiBBInstruments AB (publ) publishes information document in connection with rights issue

BiBBInstruments
Regulatory press release3/19/2026, 1:32 PM

BibbInstruments AB: BiBBInstruments resolves on the previously announced rights issue of approximately SEK 60.3 million

BiBBInstruments
Regulatory press release3/13/2026, 3:09 PM

BibbInstruments AB: Communiqué from the Extraordinary General Meeting in BiBBInstruments AB held on 13 March 2026

BiBBInstruments
Regulatory press release2/10/2026, 3:45 PM

BibbInstruments AB: Notice of Extraordinary General Meeting of BiBBInstruments AB (publ)

BiBBInstruments
Regulatory press release2/9/2026, 5:33 PM

BibbInstruments AB: BiBBInstruments Announces the Board of Directors' Intention to Resolve on a Rights Issue of Approximately SEK 60 Million

BiBBInstruments
Press release12/19/2025, 9:39 AM

BioStock: BiBBInstruments accelerates in the US – Q4 sales surge

BiBBInstruments
Regulatory press release12/17/2025, 10:16 AM

BibbInstruments AB: BiBBInstruments receives additional orders for EndoDrill[®] GI from the U.S.

BiBBInstruments
Press release12/4/2025, 1:19 PM

BioStock: BiBBInstruments validates clinical need during US tour

BiBBInstruments
Press release12/3/2025, 9:29 AM

BibbInstruments AB: U.S. Tour Fall 2025 - BiBB Strengthens Its Presence in the American Market

BiBBInstruments
Press release11/10/2025, 6:48 AM

BioStock: BiBBInstruments off the starting blocks for its U.S. launch

BiBBInstruments
Regulatory press release9/9/2025, 7:45 AM

BibbInstruments AB: Initial Results from Mayo Clinic Indicate Potential of EndoDrill GI in Tissue Culture-Based Pancreatic Cancer Research

BiBBInstruments